Clinical Use of Recombinant Factor VIII Fc and Recombinant Factor IX Fc in Patients with Hemophilia A and B

被引：0
|
作者：
Wang, Cassandra
Young, Guy
机构：
来源：
BLOOD | 2017年 / 130卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
3665
引用
收藏
页数：3
相关论文
共 50 条
  • [31] FACTOR CONSUMPTION FOR PROPHYLAXIS AND TREATMENT OF BLEEDING: RECOMBINANT FACTOR IX FC FUSION PROTEIN COMPARED WITH CONVENTIONAL RECOMBINANT FACTOR IX
    Iorio, A.
    Krishnan, S.
    Myren, K.
    Lethagen, S.
    McCormick, N.
    Kamer, P.
    VALUE IN HEALTH, 2015, 18 (07) : A660 - A660
  • [32] Physical activity in individuals with haemophilia and experience with recombinant factor VIII Fc fusion protein and recombinant factor IX Fc fusion protein for the treatment of active patients: a literature review and case reports
    Wang, Michael
    Teresa Alvarez-Roman, Maria
    Chowdary, Pratima
    Quon, Doris V.
    Schafer, Kim
    BLOOD COAGULATION & FIBRINOLYSIS, 2016, 27 (07) : 737 - 744
  • [33] Recombinant factor VIII Fc (rFVIIIFc) in real life: Clinical and economic outcomes
    Delmotte, N.
    Roche, M.
    Giraud, R.
    Roche, M.
    Falaise, C.
    Chambost, H.
    Gensollen, S.
    HAEMOPHILIA, 2019, 25 : 102 - 102
  • [34] Prolonged activity of a recombinant factor VIII-Fc fusion protein in hemophilia A mice and dogs
    Dumont, Jennifer A.
    Liu, Tongyao
    Low, Susan C.
    Zhang, Xin
    Kamphaus, George
    Sakorafas, Paul
    Fraley, Cara
    Drager, Douglas
    Reidy, Thomas
    McCue, Justin
    Franck, Helen W. G.
    Merricks, Elizabeth P.
    Nichols, Timothy C.
    Bitonti, Alan J.
    Pierce, Glenn F.
    Jiang, Haiyan
    BLOOD, 2012, 119 (13) : 3024 - 3030
  • [35] Analysis of clinical target joint bleeding on prophylactic regimens with recombinant Factor VIII Fc fusion protein in patients with severe hemophilia A
    Kulkarni, Roshni
    Ragni, Margaret V.
    Baker, Ross I.
    Pasi, John
    Manco-Johnson, Marilyn J.
    Potts, James
    Brennan, Aoife
    Pierce, Glenn F.
    HAEMOPHILIA, 2014, 20 : 94 - 94
  • [36] Cell-mediated immune response to recombinant factor VIII-Fc in hemophilia A mice
    Krishnamoorthy, S.
    Valee, S.
    Liu, T.
    Drager, D.
    Light, D.
    Pierce, G.
    Jiang, H.
    HAEMOPHILIA, 2012, 18 : 91 - 91
  • [37] Population Pharmacokinetics of Recombinant Factor VIII Fc Fusion Protein
    Nestorov, Ivan
    Neelakantan, Srividya
    Ludden, Thomas M.
    Li, Shuanglian
    Jiang, Haiyan
    Rogge, Mark
    CLINICAL PHARMACOLOGY IN DRUG DEVELOPMENT, 2015, 4 (03): : 163 - 174
  • [38] Matching-Adjusted Indirect Comparison of Recombinant Factor IX Albumin Fusion Protein Versus Recombinant Factor IX Fc Fusion Protein for Weekly Prophylactic Treatment of Hemophilia B
    Guillet, Benoit
    Yan, Songkai
    Hooper, Becky
    Drelich, Douglass
    Steenkamp, Jason
    Tomic, Radovan
    Mancuso, Maria Elisa
    ADVANCES IN THERAPY, 2024, 41 (02) : 649 - 658
  • [39] Matching-Adjusted Indirect Comparison of Recombinant Factor IX Albumin Fusion Protein Versus Recombinant Factor IX Fc Fusion Protein for Weekly Prophylactic Treatment of Hemophilia B
    Benoit Guillet
    Songkai Yan
    Becky Hooper
    Douglass Drelich
    Jason Steenkamp
    Radovan Tomic
    Maria Elisa Mancuso
    Advances in Therapy, 2024, 41 : 649 - 658
  • [40] Use of recombinant factor IX in three patients with hemophilia B undergoing surgery.
    Ragni, M
    Shapiro, A
    White, G
    Beebe, A
    Gencarella, N
    Doherty, K
    BLOOD, 1995, 86 (10) : 762 - 762
12345